[HTML][HTML] Experimental and clinical treatment of Chagas disease: a review
PAS Junior, I Molina, SMF Murta… - The American journal …, 2017 - ncbi.nlm.nih.gov
Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi that infects a
broad range of triatomines and mammalian species, including man. It afflicts 8 million …
broad range of triatomines and mammalian species, including man. It afflicts 8 million …
[HTML][HTML] Advances in the treatment of Chagas disease: Promising new drugs, plants and targets
Chagas disease, caused by Trypanosoma cruzi, is treated with only two drugs;
benznidazole and nifurtimox. These drugs have some disadvantages, including their …
benznidazole and nifurtimox. These drugs have some disadvantages, including their …
An overview of drug resistance in protozoal diseases
R Capela, R Moreira, F Lopes - International journal of molecular …, 2019 - mdpi.com
Protozoan diseases continue to be a worldwide social and economic health problem.
Increased drug resistance, emerging cross resistance, and lack of new drugs with novel …
Increased drug resistance, emerging cross resistance, and lack of new drugs with novel …
Current drug therapy and pharmaceutical challenges for Chagas disease
One of the most significant health problems in the American continent in terms of human
health, and socioeconomic impact is Chagas disease, caused by the protozoan parasite …
health, and socioeconomic impact is Chagas disease, caused by the protozoan parasite …
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects
S Patterson, S Wyllie - Trends in parasitology, 2014 - cell.com
There is an urgent need for new, safer, and effective treatments for the diseases caused by
the protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp. In …
the protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp. In …
Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease
Z Liu, R Ulrich vonBargen, AL Kendricks… - Nature …, 2023 - nature.com
Post-infectious conditions present major health burdens but remain poorly understood. In
Chagas disease (CD), caused by Trypanosoma cruzi parasites, antiparasitic agents that …
Chagas disease (CD), caused by Trypanosoma cruzi parasites, antiparasitic agents that …
[HTML][HTML] Current trends in the pharmacological management of Chagas disease
Chagas disease (CD) is a tropical neglected illness, affecting mainly populations of low
socioeconomic status in Latin America. An estimated 6 to 8 million people worldwide are …
socioeconomic status in Latin America. An estimated 6 to 8 million people worldwide are …
New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice
AK Lindner, V Lejon, F Chappuis, J Seixas… - The Lancet Infectious …, 2020 - thelancet.com
Human African trypanosomiasis caused by Trypanosoma brucei gambiense is a parasitic
infection that usually progresses to coma and death unless treated. WHO has updated its …
infection that usually progresses to coma and death unless treated. WHO has updated its …
Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches
JA Urbina - Acta tropica, 2010 - Elsevier
A critical review of the development of specific chemotherapeutic approaches for the
management of American Trypanosomiasis or Chagas disease is presented, including …
management of American Trypanosomiasis or Chagas disease is presented, including …
High-throughput decoding of antitrypanosomal drug efficacy and resistance
The concept of disease-specific chemotherapy was developed a century ago. Dyes and
arsenical compounds that displayed selectivity against trypanosomes were central to this …
arsenical compounds that displayed selectivity against trypanosomes were central to this …